Helicobacter pylori infection and gastric cancer

Paul Lochhead, Emad M El-Omar

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Gastric cancer remains a major health burden on many societies claiming hundreds of thousands of lives every year. The discovery of Helicobacter pylori has no doubt revolutionised our understanding of this malignancy, which is now regarded as a paradigm for infection-induced chronic inflammation-mediated cancer. In this paper, we discuss the evidence for the association between H. pylori and gastric adenocarcinoma and MALT lymphoma. We also discuss the pathogenesis of these two forms of cancer and the factors that determine their outcome. There is no doubt that the knowledge accumulated over the past two decades will be translated into eventual victory over this killer cancer, largely because we now appreciate that the best way to prevent the cancer is by preventing acquisition of the infection in the first place, or by eradicating the infection in infected subjects. Defining the optimal timing of intervention is going to be the challenge facing us over the next two decades.
Original languageEnglish
Pages (from-to)281-297
Number of pages17
JournalBest Practice & Research Clinical Gastroenterology
Volume21
Issue number2
DOIs
Publication statusPublished - Apr 2007

Keywords

  • Helicobacter pylori
  • gastric cancer
  • MALT lymphoma
  • host genetic factors
  • chronic gastritis
  • epidemiology
  • cytokines
  • polymorphisms
  • B-cell lymphoma
  • gastroesophageal-reflux disease
  • cytokine gene polymorphisms
  • duodenal-ulcer disease
  • necrosis-factor-alpha
  • malt-lymphoma
  • tissue lymphona
  • mongolian gerbils
  • antibiotic-treatment
  • atrophic gastritis

Cite this

Helicobacter pylori infection and gastric cancer. / Lochhead, Paul; El-Omar, Emad M.

In: Best Practice & Research Clinical Gastroenterology, Vol. 21, No. 2, 04.2007, p. 281-297.

Research output: Contribution to journalArticle

Lochhead, Paul ; El-Omar, Emad M. / Helicobacter pylori infection and gastric cancer. In: Best Practice & Research Clinical Gastroenterology. 2007 ; Vol. 21, No. 2. pp. 281-297.
@article{8117b29fc1c24057a06341fdcb15e715,
title = "Helicobacter pylori infection and gastric cancer",
abstract = "Gastric cancer remains a major health burden on many societies claiming hundreds of thousands of lives every year. The discovery of Helicobacter pylori has no doubt revolutionised our understanding of this malignancy, which is now regarded as a paradigm for infection-induced chronic inflammation-mediated cancer. In this paper, we discuss the evidence for the association between H. pylori and gastric adenocarcinoma and MALT lymphoma. We also discuss the pathogenesis of these two forms of cancer and the factors that determine their outcome. There is no doubt that the knowledge accumulated over the past two decades will be translated into eventual victory over this killer cancer, largely because we now appreciate that the best way to prevent the cancer is by preventing acquisition of the infection in the first place, or by eradicating the infection in infected subjects. Defining the optimal timing of intervention is going to be the challenge facing us over the next two decades.",
keywords = "Helicobacter pylori, gastric cancer, MALT lymphoma, host genetic factors, chronic gastritis, epidemiology, cytokines, polymorphisms, B-cell lymphoma, gastroesophageal-reflux disease, cytokine gene polymorphisms, duodenal-ulcer disease, necrosis-factor-alpha, malt-lymphoma, tissue lymphona, mongolian gerbils, antibiotic-treatment, atrophic gastritis",
author = "Paul Lochhead and El-Omar, {Emad M}",
year = "2007",
month = "4",
doi = "10.1016/j.bpg.2007.02.002",
language = "English",
volume = "21",
pages = "281--297",
journal = "Best Practice & Research Clinical Gastroenterology",
issn = "1521-6918",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

TY - JOUR

T1 - Helicobacter pylori infection and gastric cancer

AU - Lochhead, Paul

AU - El-Omar, Emad M

PY - 2007/4

Y1 - 2007/4

N2 - Gastric cancer remains a major health burden on many societies claiming hundreds of thousands of lives every year. The discovery of Helicobacter pylori has no doubt revolutionised our understanding of this malignancy, which is now regarded as a paradigm for infection-induced chronic inflammation-mediated cancer. In this paper, we discuss the evidence for the association between H. pylori and gastric adenocarcinoma and MALT lymphoma. We also discuss the pathogenesis of these two forms of cancer and the factors that determine their outcome. There is no doubt that the knowledge accumulated over the past two decades will be translated into eventual victory over this killer cancer, largely because we now appreciate that the best way to prevent the cancer is by preventing acquisition of the infection in the first place, or by eradicating the infection in infected subjects. Defining the optimal timing of intervention is going to be the challenge facing us over the next two decades.

AB - Gastric cancer remains a major health burden on many societies claiming hundreds of thousands of lives every year. The discovery of Helicobacter pylori has no doubt revolutionised our understanding of this malignancy, which is now regarded as a paradigm for infection-induced chronic inflammation-mediated cancer. In this paper, we discuss the evidence for the association between H. pylori and gastric adenocarcinoma and MALT lymphoma. We also discuss the pathogenesis of these two forms of cancer and the factors that determine their outcome. There is no doubt that the knowledge accumulated over the past two decades will be translated into eventual victory over this killer cancer, largely because we now appreciate that the best way to prevent the cancer is by preventing acquisition of the infection in the first place, or by eradicating the infection in infected subjects. Defining the optimal timing of intervention is going to be the challenge facing us over the next two decades.

KW - Helicobacter pylori

KW - gastric cancer

KW - MALT lymphoma

KW - host genetic factors

KW - chronic gastritis

KW - epidemiology

KW - cytokines

KW - polymorphisms

KW - B-cell lymphoma

KW - gastroesophageal-reflux disease

KW - cytokine gene polymorphisms

KW - duodenal-ulcer disease

KW - necrosis-factor-alpha

KW - malt-lymphoma

KW - tissue lymphona

KW - mongolian gerbils

KW - antibiotic-treatment

KW - atrophic gastritis

U2 - 10.1016/j.bpg.2007.02.002

DO - 10.1016/j.bpg.2007.02.002

M3 - Article

VL - 21

SP - 281

EP - 297

JO - Best Practice & Research Clinical Gastroenterology

JF - Best Practice & Research Clinical Gastroenterology

SN - 1521-6918

IS - 2

ER -